About Us
The AMR Policy Accelerator uses research and evidence to advise the world’s governments, public health institutions and decision makers on policies to ensure sustainable antimicrobial use for all.
Antimicrobial resistance is one of the greatest threats humanity faces today. The impact of AMR is far-reaching with consequences for human health, the global economy, the environment and global health equity–and the magnitude of this problem grows every year. In 2019, AMR was responsible for 1.27 million deaths worldwide. By 2050, it is estimated that AMR will cause 10 million deaths annually and will cumulatively cost the world economy US$100 trillion.

Our Advisory Board provides strategic and technical guidance on the prioritization of the Accelerator’s efforts to address emerging AMR policy needs at the global level. The board is composed of global leaders in the AMR and policy fields and provides representation across One Health sectors – human, animal and environmental health.
People block – please see right sidebar for options.
André Luiz de Abreu
André Luiz de Abreu is a Social Policy Analyst and Member of the Technical Group on AMR, coordinating the development and implementation of the AMR NAP with the Ministry of Health in Brazil. He is also a member of the WHO Strategic and Technical Advisory Group on Antimicrobial Resistance – STAG AMR 2024-2027 and board member of the Global AMR R&D Hub. Previously, he served as Director of the Department of Surveillance of Communicable Diseases and General Coordinator of Pu…
Amit Khurana
Amit Khurana is the Director of the Sustainable Food Systems programme at the Centre for Science and Environment (CSE) and leads the campaign on antimicrobial resistance (AMR), focussing on its animal and environmental dimensions. Amit engages with national, regional and global stakeholders and promotes policies and practices suitable to resource-constrained settings that help support sustainable food systems and equitable development.
Dr. Fajer Al Salloom
Dr. Fajer Al Saloom, is the Director of Animal Health Directorate in Animal Wealth Resources in the Ministry of Works, Municipalities Affairs & Urban Planning in the Kingdom of Bahrain. She graduated with a Bachelor of Veterinary Medical Sciences in 1994 from Cairo University in Egypt and a Master of Science in Medical Biotechnology in 2004 from Arabian Gulf University in Bahrain. She is President of the Regional Commission of the Middle East for the OIE.
Margo Warren
Margo Warren is the Director of Government Engagement & Policy at the Access to Medicine Foundation. With over a decade of experience in global health policy, she builds partnerships with governments, foundations, and multilateral organizations to advance equitable access to medicine. A recognized leader featured on the Canadian List of Women in Global Health, Margo has shaped health policy in Canada and globally through research, strategy, and evidence-based advocacy
Evelyn Wesangula
Evelyn Wesangula is a Senior AMR Control Specialist at the East Central and Southern Africa Health Community (ECSA-HC) in Arusha, Tanzania. She also serves as Vice Chair of Infection Prevention Network-Kenya, is a member of the African Union AMR Working Group, and Co- Chair of the Technical Advisory Group for the UK-Fleming Fund. Formerly Kenya’s National AMR Focal Point, Evelyn led the development of its first AMR Action Plan and continues to advance efforts to address AMR …
Observers
People block – please see right sidebar for options.
Rebecca Manaley
Rebecca Manaley is a Global Health Policy Adviser specializing in infectious diseases and AMR at Wellcome. Prior to this role, Rebecca held various positions in UK Government, including as Policy Adviser for the UK Special Envoy on AMR, and supporting UK Covid response in the Antivirals and Therapeutics Taskforce and Chief Medical Officer’s office.
Dr. Javier Yugueros-Marcos
Dr Javier Yugueros-Marcos is the Head of the AMR & Veterinary Products Department at the World Organisation for Animal Health (WOAH). After years in the field of infectious disease diagnostics development and commercialization, he now leads an international team accountable for the enhanced quality of veterinary medicines and diagnostics. He also coordinates actions supporting the responsible use of antimicrobials, in close collaboration with other Quadripartite partners.<...
The AMR Policy Accelerator Team consists of an interdisciplinary group of researchers and policy analysts with professional backgrounds in epidemiology, international law and veterinary science. Our team includes representation from all One Health sectors and is trained in providing consulting services that include an equity perspective.
People block – please see right sidebar for options.
Geneviève Boily-Larouche
Dr. Geneviève Boily-Larouche is the Managing Director of the AMR Policy Accelerator. In her role, she draws upon her significant expertise in global health research and policy to provide strategic leadership to the team, while overseeing critical policy advisory projects and day-to-day activities of the Accelerator.
Geneviève has over 15 years of experience in academic research, knowledge mobilization, science and public health policies, an…
Mathieu Poirier
Mathieu Poirier is the Director of the Global Strategy Lab, Scientific Director of the AMR Policy Accelerator, York Research Chair (Tier II) in Global Health Equity, and Associate Professor of Social Epidemiology at the School of Global Health. His research ranges from evaluating international law to developing health equity metrics and generating policy-relevant research on sociall…
Julia Bishop
Julia Bishop is the Director of Global Engagement for the Policy Team, where she leads the Policy Translation and Capacity Strengthening streams. Julia’s work focuses on strategic planning and decision-making, building meaningful partnerships, and amplifying the impact of our work through engagement with stakeholders around the world. Julia’s background is in international and human rights law; she holds a JD from Queen’s University and an LLM from the University of Cape…
Fiona Emdin
Fiona is a veterinary-research fellow at the Global Strategy Lab who supports the lab’s antimicrobial resistance policy research. Her previous policy and research experience focused on improving One Health approaches to global food security through climate-smart agricultural technologies, and infectious disease surveillance.
Fiona’s previous research and work experience was focused on improving One Health approaches to global food securit…
Taylor Hecker
Taylor is currently pursuing a Master of Public Health at the University of Ottawa, specializing in Global Health. She holds a Bachelor of Health Sciences (Honours) from the University of Calgary, where she cultivated a strong passion for research and the social determinants of health.
Taylor has also worked as a Research Coordinator with the University of Calgary’s Nephrology Research Group, focusing on person-centred integrated care and …
Alison Humphrey
Alison Humphrey plays with story across drama, digital media, and education. Since starting out as an intern at Marvel Comics, she has directed classical and live-mocapped interactive theatre, produced alternate reality games, and written transmedia television.
The research-creation dissertation for her PhD in Cinema and Media Arts, titled The Shadowpox Storyworld as Citizen Science Fiction: Building Co-Immunity through Participatory Mixed-Reality Storytelling centred on a mixed-reality storyworld co-created with young people on three continents, imagining immunization through a superhero metaphor.
Clare McGall
Clare McGall is a Policy Advisor at the AMR Policy Accelerator. In this role, she collaborates with national governments, civil society organizations, and academic researchers to provide evidence-informed AMR policy guidance.
Prior to this work, she completed her MScPH at McGill University. Her graduate education and previous research assistant experiences harnessed her skills in critical appraisal and research design.
Suzanne Naro
Suzanne Naro designs and delivers evidence-informed strategies that help governments and global institutions tackle antimicrobial resistance (AMR). She leads the development of policy frameworks, facilitates co-creation workshops with ministries of health, and supports the implementation of national AMR action plans.
Suzanne spearheaded the creation of the Smart Choice Process, a policy-responsive framework that helps countri…
Cindy Oh
Research Assistant
Cindy is a fourth year student at the University of Waterloo majoring in Public Health with a minor in Psychology. Her academic interests reflect her passion to understand how the healthcare system and policies intersect to shape the health and well-being of people.
Kadia Petricca
Dr. Kadia Petricca is the Senior Policy Lead at the Global Strategy Lab’s AMR Policy Accelerator, where she draws on her expertise in global health policy and implementation science to lead the Smart Choice process in advancing national AMR action planning with partner countries.
Kadia is deeply committed to strengthening the translation of evidence into real-world impact. She has extensive experience facilitating policy dialogues with …
Heba Qazilbash
Heba is a dedicated public health professional committed to advancing social justice, health equity and improving health outcomes for marginalized communities worldwide. She has served as a Policy Analyst in the Office of International Affairs at the Public Health Agency of Canada, contributing to Canada’s international health engagement, and has conducted extensive research on access to medicines, human rights, and the impact of COVID-19 on healthcare workers and students.&…
Arne Ruckert
Arne Ruckert is the Director of Research at the Global Strategy Lab’s AMR Policy Accelerator, overseeing all research activities and contributing to the development of policy products. His previous academic work revolved around understanding how social determinants of health are driving global health inequities, using political economy and social sciences approaches. More recently, he has researched the governance and surveillance of antimicrobial resistance (AMR) drawing on t…
Kayla Strong
Kayla Strong is the Capacity Strengthening Lead at the Global Strategy Lab, where she synthesizes and translates evidence specific to antimicrobial resistance and supports study design development. She completed her Ph.D. in Veterinary Medicine at the University of Calgary, specializing in antimicrobial resistance transmission modelling within beef supply chain operations, aiming to influence both policy and practice in the Canadian beef industry. Kayla is deeply passionate …
Ramdhanie Sukhai
Finance Officer
Ramdhanie holds a Master of Business Administration and a Bachelor of Social Science Degree in Economics from the University of Guyana. He is also a certified Project Manager (PMP) and is trained in financial management, results-based budgeting and monitoring & evaluation.
Demetria Tsoutouras
Director of Communications
Demetria heads communications strategy and planning at the Global Strategy Lab and is a member of the AMR Policy Accelerator leadership team. Demetria’s role includes working with the team to develop comprehensive dissemination plans, exploring strategies to make GSL’s research more accessible to key audiences and encouraging a culture of strategic communication.
Lauren J. Wallace
Dr. Lauren J. Wallace is a Research Associate at the Global Strategy Lab, where she uses her expertise as a medical anthropologist to synthesize research on the complex social components of AMR.
As a member of the AMR Policy Accelerator team, Lauren spearheads evidence synthesis focused on unpacking the pathways between gender, equity and AMR. She also contributes to research on the design of a global governance panel on evidence for action …
People block – please see right sidebar for options.
Patrick Fafard
Patrick Fafard is a Senior Investigator with the Global Strategy Lab and Full Professor cross-appointed to the Faculties of Social Science and Medicine, University of Ottawa. Earlier in his career he served as a senior executive with the governments of Canada and Saskatchewan. His current research focuses on public health policy and governance and the role of scientific evidence in the making of public policy.
A.M. Viens
Dr. A.M. Viens is York Research Chair in Population Health Ethics and Law and Inaugural Director of the School of Global Health at York University. He is also a member of the WHO Collaborating Centre for Global Governance of Antimicrobial Resistance. He has degrees in philosophy and law from the Universities of Toronto, Oxford, and London. A key area of his research focus centres on demonstrating how philosophical analysis, legal epidemiology, and regulatory theory should shap…
